Resolving controversies on the path to Alzheimer's therapeutics.

摘要

In the version of this article initially published, the name of the antibody bapineuzumab was incorrectly spelled as 'bapineuzimab' throughout the text. The error has been corrected in the HTML and PDF versions of the article.